New protocol developed to treat bleeding risk of rare type of leukemia

01/28/2013 | Augusta Chronicle (Ga.), The

The Georgia Regents University Cancer Center is leading a group of Southeastern hospitals in implementing a new treatment protocol for acute promyelocytic leukemia, a rare and potentially fatal illness that can limit coagulation and induce severe bleeding. The five-center effort has received a $1.67 million, five-year grant. The protocol includes treatment with all-trans-retinoic acid and blood transfusions.

View Full Article in:

Augusta Chronicle (Ga.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT